HeartSciences (HSCS) Current Assets (2022 - 2025)
HeartSciences (HSCS) posted quarterly Current Assets of $2.2 million for Q4 2025, down 42.76% on a QoQ basis from $3.8 million in Q4 2025.
HeartSciences (HSCS) Current Assets (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has reported Current Assets for 4 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.
- Quarterly Current Assets changed N/A year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (changed N/A YoY) and the FY2025 annual result came in at $2.2 million, down 70.47% from the prior year.
- Current Assets slipped to $2.2 million in Q4 2025 per HSCS's latest filing, from $3.8 million in the prior quarter.
- Over the last five years, Current Assets for HSCS reached as high as $8.7 million in Q1 2024 and fell as low as $1.8 million in Q4 2023.
- A 4-year average of $4.1 million and a median of $3.7 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets surged 213.93% — and 2025, when it tumbled 70.47%.
- Year by year, Current Assets stood at $4.1 million in 2022, then tumbled by 56.09% to $1.8 million in 2023, then jumped by 213.93% to $5.7 million in 2024, then sank by 61.83% to $2.2 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $2.2 million, $3.8 million, and $4.4 million for Q4 2025, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.17 Mn |
| Oct 31, 2025 | 3.79 Mn |
| Jul 31, 2025 | 4.42 Mn |
| Apr 30, 2025 | 2.17 Mn |
| Jan 31, 2025 | 3.63 Mn |
| Oct 31, 2024 | 5.69 Mn |
| Jul 31, 2024 | 6.07 Mn |
| Apr 30, 2024 | 7.35 Mn |
| Jan 31, 2024 | 8.69 Mn |
| Oct 31, 2023 | 1.81 Mn |
| Jul 31, 2023 | 2.03 Mn |
| Apr 30, 2023 | 2.70 Mn |
| Jan 31, 2023 | 2.87 Mn |
| Oct 31, 2022 | 4.13 Mn |
| Jul 31, 2022 | 5.44 Mn |
| Apr 30, 2022 | 1.93 Mn |